Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Narrow the list

Filters

Showing 21–40 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

21
FDA reviewU.S. Food and Drug Administration · 2022Checked 2026-08-30

FDA review: tirzepatide's 39-amino-acid structure

Reviews using this sourceTirzepatide
Open source
22
Randomized trialPubMed · New England Journal of Medicine · 2022Checked 2026-08-30

Tirzepatide once weekly for the treatment of obesity

Reviews using this sourceTirzepatide
Open source
23
Randomized trialPubMed · New England Journal of Medicine · 2021Checked 2026-08-30

Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes

Reviews using this sourceTirzepatide
Open source
24
FDA reviewU.S. Food and Drug Administration · 2026Checked 2026-07-23

July 2026 PCAC briefing on BPC-157-related bulk drug substances

Reviews using this sourceBPC-157
Open source
26
Science reviewPubMed · Pharmaceutics · 2026Checked 2026-07-23

BPC-157 as an investigational peptide therapeutic: translational development barriers

Reviews using this sourceBPC-157
Open source
27
Human pilotPubMed · Alternative Therapies in Health and Medicine · 2025Checked 2026-07-23

Safety of intravenous infusion of BPC157 in humans: a pilot study

Reviews using this sourceBPC-157
Open source
28
PreclinicalPubMed · Journal of Applied Physiology · 2011Checked 2026-07-23

Promoting effect of BPC 157 on tendon healing: tendon outgrowth, cell survival, and migration

Reviews using this sourceBPC-157
Open source
30
Trial registryClinicalTrials.gov · 2026Checked 2026-07-23

BPC 157 for acute hamstring muscle strain repair

Reviews using this sourceBPC-157
Open source
31
Randomized trialPubMed · Journal of Clinical Endocrinology & Metabolism · 2006Checked 2026-07-23

Prolonged GH and IGF-1 stimulation by CJC-1295 in healthy adults

Reviews using this sourceCJC-1295
Open source
32
Human pharmacologyPubMed · Journal of Clinical Endocrinology & Metabolism · 2006Checked 2026-07-23

Pulsatile GH secretion during continuous stimulation by CJC-1295

Reviews using this sourceCJC-1295
Open source
33
FDA reviewU.S. Food and Drug Administration · 2024Checked 2026-07-23

CJC-1295 pharmacy compounding advisory review

Reviews using this sourceCJC-1295
Open source
34
Human pharmacologyPubMed · Pharmaceutical Research · 1999Checked 2026-07-23

Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers

Reviews using this sourceIpamorelin
Open source
35
Randomized trialPubMed · International Journal of Colorectal Disease · 2015Checked 2026-07-23

Randomized proof-of-concept study of ipamorelin for postoperative ileus

Reviews using this sourceIpamorelin
Open source
36
Drug labelU.S. Food and Drug Administration · 2024Checked 2026-07-23

VICTOZA (liraglutide) prescribing information

Reviews using this sourceLiraglutide
Open source
37
Drug labelU.S. Food and Drug Administration · 2026Checked 2026-07-23

SAXENDA (liraglutide) prescribing information

Reviews using this sourceLiraglutide
Open source
38
Randomized trialPubMed · New England Journal of Medicine · 2016Checked 2026-07-23

Liraglutide and cardiovascular outcomes in type 2 diabetes

Reviews using this sourceLiraglutide
Open source
39
Human pharmacologyPubMed · The Lancet · 2022Checked 2026-07-23

LY3437943 in people with type 2 diabetes: a phase 1b randomized trial

Reviews using this sourceRetatrutide
Open source
40
Randomized trialPubMed · The Lancet · 2023Checked 2026-07-23

Retatrutide for people with type 2 diabetes: a phase 2 randomized trial

Reviews using this sourceRetatrutide
Open source

About this list

How this list works

This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.